Abstract
Summary
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The global Neurological Biomarkers market is projected to reach US$ 15480 million by 2030 from an estimated US$ 7840.2 million in 2024, at a CAGR of 12.0% during 2024 and 2030.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers.
The Neurological Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurological Biomarkers market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurological Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurological Biomarkers sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Neurological Biomarkers market is projected to reach US$ 15480 million by 2030 from an estimated US$ 7840.2 million in 2024, at a CAGR of 12.0% during 2024 and 2030.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers.
The Neurological Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurological Biomarkers market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurological Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurological Biomarkers sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurological Biomarkers Market Size Estimates and Forecasts
2.1.1 Global Neurological Biomarkers Revenue 2019-2030
2.1.2 Global Neurological Biomarkers Sales 2019-2030
2.2 Neurological Biomarkers Market Size by Region: 2023 Versus 2030
2.3 Neurological Biomarkers Sales by Region (2019-2030)
2.3.1 Global Neurological Biomarkers Sales by Region: 2019-2024
2.3.2 Global Neurological Biomarkers Sales Forecast by Region (2025-2030)
2.3.3 Global Neurological Biomarkers Sales Market Share by Region (2019-2030)
2.4 Neurological Biomarkers Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Neurological Biomarkers Revenue by Region: 2019-2024
2.4.2 Global Neurological Biomarkers Revenue Forecast by Region (2025-2030)
2.4.3 Global Neurological Biomarkers Revenue Market Share by Region (2019-2030)
3 Global Neurological Biomarkers by Manufacturers
3.1 Global Top Neurological Biomarkers Manufacturers by Sales
3.1.1 Global Neurological Biomarkers Sales by Manufacturer (2019-2024)
3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Neurological Biomarkers Manufacturers by Revenue
3.2.1 Global Neurological Biomarkers Revenue by Manufacturer (2019-2024)
3.2.2 Global Neurological Biomarkers Revenue Share by Manufacturer (2019-2024)
3.3 Global Neurological Biomarkers Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Neurological Biomarkers Manufacturers Covered: Ranking by Revenue
3.4.2 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Neurological Biomarkers Manufacturing Base Distribution, Product Type
3.5.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Neurological Biomarkers Product Type
3.5.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Company Information
4.1.2 Thermo Fisher Scientific Description, Business Overview
4.1.3 Thermo Fisher Scientific Neurological Biomarkers Products Offered
4.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Thermo Fisher Scientific Neurological Biomarkers Sales by Product in 2023
4.1.6 Thermo Fisher Scientific Neurological Biomarkers Sales by Application in 2023
4.1.7 Thermo Fisher Scientific Neurological Biomarkers Sales by Geographic Area in 2023
4.1.8 Thermo Fisher Scientific Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Description, Business Overview
4.2.3 Merck Neurological Biomarkers Products Offered
4.2.4 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Merck Neurological Biomarkers Sales by Product in 2023
4.2.6 Merck Neurological Biomarkers Sales by Application in 2023
4.2.7 Merck Neurological Biomarkers Sales by Geographic Area in 2023
4.2.8 Merck Recent Developments
4.3 Quest Diagnostics
4.3.1 Quest Diagnostics Company Information
4.3.2 Quest Diagnostics Description, Business Overview
4.3.3 Quest Diagnostics Neurological Biomarkers Products Offered
4.3.4 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Quest Diagnostics Neurological Biomarkers Sales by Product in 2023
4.3.6 Quest Diagnostics Neurological Biomarkers Sales by Application in 2023
4.3.7 Quest Diagnostics Neurological Biomarkers Sales by Geographic Area in 2023
4.3.8 Quest Diagnostics Recent Developments
4.4 Abbott
4.4.1 Abbott Company Information
4.4.2 Abbott Description, Business Overview
4.4.3 Abbott Neurological Biomarkers Products Offered
4.4.4 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Abbott Neurological Biomarkers Sales by Product in 2023
4.4.6 Abbott Neurological Biomarkers Sales by Application in 2023
4.4.7 Abbott Neurological Biomarkers Sales by Geographic Area in 2023
4.4.8 Abbott Recent Developments
4.5 Roche
4.5.1 Roche Company Information
4.5.2 Roche Description, Business Overview
4.5.3 Roche Neurological Biomarkers Products Offered
4.5.4 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Roche Neurological Biomarkers Sales by Product in 2023
4.5.6 Roche Neurological Biomarkers Sales by Application in 2023
4.5.7 Roche Neurological Biomarkers Sales by Geographic Area in 2023
4.5.8 Roche Recent Developments
4.6 Illumina
4.6.1 Illumina Company Information
4.6.2 Illumina Description, Business Overview
4.6.3 Illumina Neurological Biomarkers Products Offered
4.6.4 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Illumina Neurological Biomarkers Sales by Product in 2023
4.6.6 Illumina Neurological Biomarkers Sales by Application in 2023
4.6.7 Illumina Neurological Biomarkers Sales by Geographic Area in 2023
4.6.8 Illumina Recent Development
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Company Information
4.7.2 Bio-Rad Laboratories Description, Business Overview
4.7.3 Bio-Rad Laboratories Neurological Biomarkers Products Offered
4.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Bio-Rad Laboratories Neurological Biomarkers Sales by Product in 2023
4.7.6 Bio-Rad Laboratories Neurological Biomarkers Sales by Application in 2023
4.7.7 Bio-Rad Laboratories Neurological Biomarkers Sales by Geographic Area in 2023
4.7.8 Bio-Rad Laboratories Recent Development
4.8 QIAGEN
4.8.1 QIAGEN Company Information
4.8.2 QIAGEN Description, Business Overview
4.8.3 QIAGEN Neurological Biomarkers Products Offered
4.8.4 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.8.5 QIAGEN Neurological Biomarkers Sales by Product in 2023
4.8.6 QIAGEN Neurological Biomarkers Sales by Application in 2023
4.8.7 QIAGEN Neurological Biomarkers Sales by Geographic Area in 2023
4.8.8 QIAGEN Recent Development
4.9 Myriad RBM
4.9.1 Myriad RBM Company Information
4.9.2 Myriad RBM Description, Business Overview
4.9.3 Myriad RBM Neurological Biomarkers Products Offered
4.9.4 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Myriad RBM Neurological Biomarkers Sales by Product in 2023
4.9.6 Myriad RBM Neurological Biomarkers Sales by Application in 2023
4.9.7 Myriad RBM Neurological Biomarkers Sales by Geographic Area in 2023
4.9.8 Myriad RBM Recent Development
4.10 Cisbio Bioassays
4.10.1 Cisbio Bioassays Company Information
4.10.2 Cisbio Bioassays Description, Business Overview
4.10.3 Cisbio Bioassays Neurological Biomarkers Products Offered
4.10.4 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Cisbio Bioassays Neurological Biomarkers Sales by Product in 2023
4.10.6 Cisbio Bioassays Neurological Biomarkers Sales by Application in 2023
4.10.7 Cisbio Bioassays Neurological Biomarkers Sales by Geographic Area in 2023
4.10.8 Cisbio Bioassays Recent Development
4.11 Athena Diagnostics
4.11.1 Athena Diagnostics Company Information
4.11.2 Athena Diagnostics Description, Business Overview
4.11.3 Athena Diagnostics Neurological Biomarkers Products Offered
4.11.4 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Athena Diagnostics Neurological Biomarkers Sales by Product in 2023
4.11.6 Athena Diagnostics Neurological Biomarkers Sales by Application in 2023
4.11.7 Athena Diagnostics Neurological Biomarkers Sales by Geographic Area in 2023
4.11.8 Athena Diagnostics Recent Development
4.12 BGI
4.12.1 BGI Company Information
4.12.2 BGI Description, Business Overview
4.12.3 BGI Neurological Biomarkers Products Offered
4.12.4 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.12.5 BGI Neurological Biomarkers Sales by Product in 2023
4.12.6 BGI Neurological Biomarkers Sales by Application in 2023
4.12.7 BGI Neurological Biomarkers Sales by Geographic Area in 2023
4.12.8 BGI Recent Development
4.13 Wuxi APP
4.13.1 Wuxi APP Company Information
4.13.2 Wuxi APP Description, Business Overview
4.13.3 Wuxi APP Neurological Biomarkers Products Offered
4.13.4 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.13.5 Wuxi APP Neurological Biomarkers Sales by Product in 2023
4.13.6 Wuxi APP Neurological Biomarkers Sales by Application in 2023
4.13.7 Wuxi APP Neurological Biomarkers Sales by Geographic Area in 2023
4.13.8 Wuxi APP Recent Development
4.14 Aepodia
4.14.1 Aepodia Company Information
4.14.2 Aepodia Description, Business Overview
4.14.3 Aepodia Neurological Biomarkers Products Offered
4.14.4 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.14.5 Aepodia Neurological Biomarkers Sales by Product in 2023
4.14.6 Aepodia Neurological Biomarkers Sales by Application in 2023
4.14.7 Aepodia Neurological Biomarkers Sales by Geographic Area in 2023
4.14.8 Aepodia Recent Development
4.15 Proteome Sciences
4.15.1 Proteome Sciences Company Information
4.15.2 Proteome Sciences Description, Business Overview
4.15.3 Proteome Sciences Neurological Biomarkers Products Offered
4.15.4 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.15.5 Proteome Sciences Neurological Biomarkers Sales by Product in 2023
4.15.6 Proteome Sciences Neurological Biomarkers Sales by Application in 2023
4.15.7 Proteome Sciences Neurological Biomarkers Sales by Geographic Area in 2023
4.15.8 Proteome Sciences Recent Development
4.16 Genewiz
4.16.1 Genewiz Company Information
4.16.2 Genewiz Description, Business Overview
4.16.3 Genewiz Neurological Biomarkers Products Offered
4.16.4 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2019-2024)
4.16.5 Genewiz Neurological Biomarkers Sales by Product in 2023
4.16.6 Genewiz Neurological Biomarkers Sales by Application in 2023
4.16.7 Genewiz Neurological Biomarkers Sales by Geographic Area in 2023
4.16.8 Genewiz Recent Development
5 Breakdown Data by Type
5.1 Global Neurological Biomarkers Sales by Type (2019-2030)
5.1.1 Global Neurological Biomarkers Sales by Type (2019-2024)
5.1.2 Global Neurological Biomarkers Sales Forecast by Type (2025-2030)
5.1.3 Global Neurological Biomarkers Sales Market Share by Type (2019-2030)
5.2 Global Neurological Biomarkers Revenue Forecast by Type (2019-2030)
5.2.1 Global Neurological Biomarkers Revenue by Type (2019-2024)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2025-2030)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2019-2030)
5.3 Neurological Biomarkers Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Neurological Biomarkers Sales by Application (2019-2030)
6.1.1 Global Neurological Biomarkers Sales by Application (2019-2024)
6.1.2 Global Neurological Biomarkers Sales Forecast by Application (2025-2030)
6.1.3 Global Neurological Biomarkers Sales Market Share by Application (2019-2030)
6.2 Global Neurological Biomarkers Revenue Forecast by Application (2019-2030)
6.2.1 Global Neurological Biomarkers Revenue by Application (2019-2024)
6.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2025-2030)
6.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2019-2030)
6.3 Neurological Biomarkers Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Neurological Biomarkers Market Size YoY Growth 2019-2030
7.2 North America Neurological Biomarkers Market Facts & Figures by Country
7.2.1 North America Neurological Biomarkers Sales by Country (2019-2030)
7.2.2 North America Neurological Biomarkers Revenue by Country (2019-2030)
7.3 North America Neurological Biomarkers Sales by Type (2019-2024)
7.4 North America Neurological Biomarkers Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Neurological Biomarkers Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Neurological Biomarkers Market Facts & Figures by Region
8.2.1 Asia-Pacific Neurological Biomarkers Sales by Region (2019-2030)
8.2.2 Asia-Pacific Neurological Biomarkers Revenue by Region (2019-2030)
8.3 Asia-Pacific Neurological Biomarkers Sales by Type (2019-2024)
8.4 Asia-Pacific Neurological Biomarkers Sales by Application (2019-2024)
9 Europe
9.1 Europe Neurological Biomarkers Market Size YoY Growth 2019-2030
9.2 Europe Neurological Biomarkers Market Facts & Figures by Country
9.2.1 Europe Neurological Biomarkers Sales by Country (2019-2030)
9.2.2 Europe Neurological Biomarkers Revenue by Country (2019-2030)
9.3 Europe Neurological Biomarkers Sales by Type (2019-2024)
9.4 Europe Neurological Biomarkers Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Neurological Biomarkers Market Size YoY Growth 2019-2030
10.2 Latin America Neurological Biomarkers Market Facts & Figures by Country
10.2.1 Latin America Neurological Biomarkers Sales by Country (2019-2030)
10.2.2 Latin America Neurological Biomarkers Revenue by Country (2019-2030)
10.3 Latin America Neurological Biomarkers Sales by Type (2019-2024)
10.4 Latin America Neurological Biomarkers Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurological Biomarkers Sales by Country (2019-2030)
11.2.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2019-2030)
11.3 Middle East and Africa Neurological Biomarkers Sales by Type (2019-2024)
11.4 Middle East and Africa Neurological Biomarkers Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Neurological Biomarkers Supply Chain Analysis
12.2 Neurological Biomarkers Key Raw Materials and Upstream Suppliers
12.3 Neurological Biomarkers Clients Analysis
12.4 Neurological Biomarkers Sales Channel and Sales Model Analysis
12.4.1 Neurological Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Neurological Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Neurological Biomarkers Distributors
13 Market Dynamics
13.1 Neurological Biomarkers Industry Trends
13.2 Neurological Biomarkers Market Drivers
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer